Japan Cancer Biologic Therapy Market

ID: MRFR/Pharma/52693-HCR
200 Pages
Rahul Gotadki
Last Updated: July 15, 2026
Japan Cancer Biologic Therapy Market Research Report By Type of Therapy (Monoclonal Antibodies, Vaccines, Cytokines, Gene Therapy), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer), By Administration Route (Intravenous, Subcutaneous, Oral, Intramuscular) and By End User (Hospitals, Cancer Research Institutes, Pharmaceutical Companies) - Growth & Industry Forecast 2025 To 2035
Japan Cancer Biologic Therapy Market
Market Size
Forecast Period2025-2035
CAGR (2025-2035)5.73%
2023 Market Size$ 6.82 Billion
2024 Market Size$ 7.1 Billion
2035 Market Size$ 13.1 Billion
Key Players
Gilead Sciences
Takeda Pharmaceutical Company
Astellas Pharma
Novartis
Mitsubishi Tanabe Pharma
Regeneron Pharmaceuticals
Trends
  • Genomic Sequencing Drives Personalized Treatment Adoption
  • International Collaborations and Regulatory Reform Expand Innovation
Opportunities
  • Innovation in Immunotherapy and Next-Generation Biopharmaceuticals
  • Growing Adoption of Precision Oncology and Personalized Biologic Therapies
Summary Table of Contents Segmentation Download PDF
  1. EXECUTIVE SUMMARY
    1. Market Overview
    2. Key Findings
    3. Market Segmentation
    4. Competitive Landscape
    5. Challenges and Opportunities
    6. Future Outlook
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the study
    3. Research Objective
    4. Assumption
    5. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
    5. Primary Interviews and Information Gathering Process
    6. Breakdown of Primary Respondents
    7. Forecasting Model
    8. Market Size Estimation
    9. Bottom-Up Approach
    10. Top-Down Approach
    11. Data Triangulation
    12. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Value chain Analysis
    2. Porter's Five Forces Analysis
    3. Bargaining Power of Suppliers
    4. Bargaining Power of Buyers
    5. Threat of New Entrants
    6. Threat of Substitutes
    7. Intensity of Rivalry
    8. COVID-19 Impact Analysis
    9. Market Impact Analysis
    10. Regional Impact
    11. Opportunity and Threat Analysis
  6. Japan Japan Cancer Biologic Therapy Market, BY Type of Therapy (USD Billion)
    1. Monoclonal Antibodies
    2. Vaccines
    3. Cytokines
    4. Gene Therapy
  7. Japan Cancer Biologic Japan Cancer Biologic Therapy Market, BY Cancer Type (USD Billion)
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
  8. Japan Japan Cancer Biologic Therapy Market, BY Administration Route (USD Billion)
    1. Intravenous
    2. Subcutaneous
    3. Oral
    4. Intramuscular
  9. Japan Japan Cancer Biologic Therapy Market, BY End User (USD Billion)
    1. Hospitals
    2. Cancer Research Institutes
    3. Pharmaceutical Companies
    4. Competitive Landscape
    5. Overview
    6. Competitive Analysis
    7. Market share Analysis
    8. Major Growth Strategy in the Cancer Biologic Therapy Market
    9. Competitive Benchmarking
    10. Leading Players in Terms of Number of Developments in the Cancer Biologic Therapy Market
    11. Key developments and growth strategies
    12. New Product Launch/Service Deployment
    13. Merger & Acquisitions
    14. Joint Ventures
    15. Major Players Financial Matrix
    16. Sales and Operating Income
    17. Major Players R&D Expenditure. 2023
    18. Company Profiles
    19. Gilead Sciences
    20. Financial Overview
    21. Products Offered
    22. Key Developments
    23. SWOT Analysis
    24. Key Strategies
    25. Takeda Pharmaceutical Company
    26. Financial Overview
    27. Products Offered
    28. Key Developments
    29. SWOT Analysis
    30. Key Strategies
    31. Astellas Pharma
    32. Financial Overview
    33. Products Offered
    34. Key Developments
    35. SWOT Analysis
    36. Key Strategies
    37. Novartis
    38. Financial Overview
    39. Products Offered
    40. Key Developments
    41. SWOT Analysis
    42. Key Strategies
    43. Mitsubishi Tanabe Pharma
    44. Financial Overview
    45. Products Offered
    46. Key Developments
    47. SWOT Analysis
    48. Key Strategies
    49. Regeneron Pharmaceuticals
    50. Financial Overview
    51. Products Offered
    52. Key Developments
    53. SWOT Analysis
    54. Key Strategies
    55. Sanofi
    56. Financial Overview
    57. Products Offered
    58. Key Developments
    59. SWOT Analysis
    60. Key Strategies
    61. Amgen
    62. Financial Overview
    63. Products Offered
    64. Key Developments
    65. SWOT Analysis
    66. Key Strategies
    67. Johnson & Johnson
    68. Financial Overview
    69. Products Offered
    70. Key Developments
    71. SWOT Analysis
    72. Key Strategies
    73. Eli Lilly and Company
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. Merck & Co
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. BristolMyers Squibb
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Daiichi Sankyo
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Pfizer
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Roche
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Appendix
    110. References
    111. Related Reports
    112. LIST Of tables
  10. LIST OF ASSUMPTIONS
  11. Japan Cancer Biologic Therapy Market SIZE ESTIMATES & Japan Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019-2035 (USD Billions)
  12. Japan Cancer Biologic Therapy Market SIZE ESTIMATES & Japan Cancer Biologic Therapy Market, BY CANCER TYPE, 2019-2035 (USD Billions)
  13. Japan Cancer Biologic Therapy Market SIZE ESTIMATES & Japan Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
  14. Japan Cancer Biologic Therapy Market SIZE ESTIMATES & Japan Cancer Biologic Therapy Market, BY END USER, 2019-2035 (USD Billions)
    1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    2. ACQUISITION/PARTNERSHIP
    3. LIST Of figures
  15. MARKET SYNOPSIS
    1. JAPAN CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY TYPE OF THERAPY
    2. JAPAN CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY CANCER TYPE
    3. JAPAN CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY ADMINISTRATION ROUTE
    4. JAPAN CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY END USER
  16. KEY BUYING CRITERIA OF CANCER BIOLOGIC THERAPY MARKET
    1. RESEARCH PROCESS OF MRFR
  17. DRO ANALYSIS OF CANCER BIOLOGIC THERAPY MARKET
    1. DRIVERS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
    2. RESTRAINTS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
    3. SUPPLY / VALUE CHAIN: CANCER BIOLOGIC THERAPY MARKET
  18. Japan Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2025 (% SHARE)
  19. Japan Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019 TO 2035 (USD Billions)
  20. CANCER BIOLOGIC Japan Cancer Biologic Therapy Market, BY CANCER TYPE, 2025 (% SHARE)
  21. CANCER Japan Cancer Biologic Therapy Market, BY CANCER TYPE, 2019 TO 2035 (USD Billions)
  22. CANCER Japan Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
  23. CANCER Japan Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
  24. CANCER Japan Cancer Biologic Therapy Market, BY END USER, 2025 (% SHARE)
  25. CANCER Japan Cancer Biologic Therapy Market, BY END USER, 2019 TO 2035 (USD Billions)
    1. BENCHMARKING OF MAJOR COMPETITORS

Japan Cancer Biologic Therapy Market Segmentation

 

 

 

  • Japan Cancer Biologic Therapy Market By Type of Therapy (USD Billion, 2019-2035)

    • Monoclonal Antibodies
    • Vaccines
    • Cytokines
    • Gene Therapy

 

  • Japan Cancer Biologic Therapy Market By Cancer Type (USD Billion, 2019-2035)

    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer

 

  • Japan Cancer Biologic Therapy Market By Administration Route (USD Billion, 2019-2035)

    • Intravenous
    • Subcutaneous
    • Oral
    • Intramuscular

 

  • Japan Cancer Biologic Therapy Market By End User (USD Billion, 2019-2035)

    • Hospitals
    • Cancer Research Institutes
    • Japan Cancer Biologic Therapy Market Companies

 

 

 

 

 

 

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.